Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
6 Jan 25 | RNAC Cartesian Therapeutics | Common Stock | Sell | Dispose S | No | No | 16.8322 | 4,028 | 67.80 k | 94,811 |
3 Jan 25 | RNAC Cartesian Therapeutics | Common Stock | Sell | Dispose S | No | No | 16.7219 | 3,961 | 66.24 k | 98,839 |
2 Jan 25 | RNAC Cartesian Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 22,000 | 0.00 | 102,800 |
2 Jan 25 | RNAC Cartesian Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 16.93 | 64,600 | 1.09 mm | 64,600 |
2 Jan 24 | RNAC Cartesian Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 2,424,000 | 0.00 | 2,424,000 |
2 Jan 24 | RNAC Cartesian Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 0.6552 | 3,110,000 | 2.04 mm | 3,110,000 |
13 Nov 23 | RNAC Cartesian Therapeutics | Employee Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.79 | 1,250,000 | 987.50 k | 0 |